Aneurysmal Subarachnoid Hemorrhage Drugs - Global Market Insights and Sales Trends 2024

Aneurysmal Subarachnoid Hemorrhage Drugs - Global Market Insights and Sales Trends 2024

Table of Contents
1 Aneurysmal Subarachnoid Hemorrhage Drugs Market Overview
1.1 Aneurysmal Subarachnoid Hemorrhage Drugs Product Overview
1.2 Aneurysmal Subarachnoid Hemorrhage Drugs Market Segment by Type
1.2.1 Opioid Analgesic
1.2.2 Calcium Channel Blocker
1.2.3 Anticonvulsant
1.2.4 Stool Softener
1.2.5 Osmotic Agent
1.2.6 Other Drugs
1.3 Global Aneurysmal Subarachnoid Hemorrhage Drugs Market Size by Type
1.3.1 Global Aneurysmal Subarachnoid Hemorrhage Drugs Market Size Overview by Type (2018-2029)
1.3.2 Global Aneurysmal Subarachnoid Hemorrhage Drugs Historic Market Size Review by Type (2018-2023)
1.3.3 Global Aneurysmal Subarachnoid Hemorrhage Drugs Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Aneurysmal Subarachnoid Hemorrhage Drugs Sales Breakdown by Type (2018-2023)
1.4.2 Europe Aneurysmal Subarachnoid Hemorrhage Drugs Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Aneurysmal Subarachnoid Hemorrhage Drugs Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Aneurysmal Subarachnoid Hemorrhage Drugs Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Aneurysmal Subarachnoid Hemorrhage Drugs Sales Breakdown by Type (2018-2023)
2 Global Aneurysmal Subarachnoid Hemorrhage Drugs Market Competition by Company
2.1 Global Top Players by Aneurysmal Subarachnoid Hemorrhage Drugs Sales (2018-2023)
2.2 Global Top Players by Aneurysmal Subarachnoid Hemorrhage Drugs Revenue (2018-2023)
2.3 Global Top Players by Aneurysmal Subarachnoid Hemorrhage Drugs Price (2018-2023)
2.4 Global Top Manufacturers Aneurysmal Subarachnoid Hemorrhage Drugs Manufacturing Base Distribution, Sales Area, Product Type
2.5 Aneurysmal Subarachnoid Hemorrhage Drugs Market Competitive Situation and Trends
2.5.1 Aneurysmal Subarachnoid Hemorrhage Drugs Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Aneurysmal Subarachnoid Hemorrhage Drugs Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Aneurysmal Subarachnoid Hemorrhage Drugs as of 2022)
2.7 Date of Key Manufacturers Enter into Aneurysmal Subarachnoid Hemorrhage Drugs Market
2.8 Key Manufacturers Aneurysmal Subarachnoid Hemorrhage Drugs Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Aneurysmal Subarachnoid Hemorrhage Drugs Status and Outlook by Region
3.1 Global Aneurysmal Subarachnoid Hemorrhage Drugs Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Aneurysmal Subarachnoid Hemorrhage Drugs Historic Market Size by Region
3.2.1 Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales in Volume by Region (2018-2023)
3.2.2 Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales in Value by Region (2018-2023)
3.2.3 Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Aneurysmal Subarachnoid Hemorrhage Drugs Forecasted Market Size by Region
3.3.1 Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales in Volume by Region (2024-2029)
3.3.2 Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales in Value by Region (2024-2029)
3.3.3 Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Aneurysmal Subarachnoid Hemorrhage Drugs by Application
4.1 Aneurysmal Subarachnoid Hemorrhage Drugs Market Segment by Application
4.1.1 Hospital
4.1.2 Clinic
4.1.3 Others
4.2 Global Aneurysmal Subarachnoid Hemorrhage Drugs Market Size by Application
4.2.1 Global Aneurysmal Subarachnoid Hemorrhage Drugs Market Size Overview by Application (2018-2029)
4.2.2 Global Aneurysmal Subarachnoid Hemorrhage Drugs Historic Market Size Review by Application (2018-2023)
4.2.3 Global Aneurysmal Subarachnoid Hemorrhage Drugs Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Aneurysmal Subarachnoid Hemorrhage Drugs Sales Breakdown by Application (2018-2023)
4.3.2 Europe Aneurysmal Subarachnoid Hemorrhage Drugs Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Aneurysmal Subarachnoid Hemorrhage Drugs Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Aneurysmal Subarachnoid Hemorrhage Drugs Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Aneurysmal Subarachnoid Hemorrhage Drugs Sales Breakdown by Application (2018-2023)
5 North America Aneurysmal Subarachnoid Hemorrhage Drugs by Country
5.1 North America Aneurysmal Subarachnoid Hemorrhage Drugs Historic Market Size by Country
5.1.1 North America Aneurysmal Subarachnoid Hemorrhage Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Aneurysmal Subarachnoid Hemorrhage Drugs Sales in Volume by Country (2018-2023)
5.1.3 North America Aneurysmal Subarachnoid Hemorrhage Drugs Sales in Value by Country (2018-2023)
5.2 North America Aneurysmal Subarachnoid Hemorrhage Drugs Forecasted Market Size by Country
5.2.1 North America Aneurysmal Subarachnoid Hemorrhage Drugs Sales in Volume by Country (2024-2029)
5.2.2 North America Aneurysmal Subarachnoid Hemorrhage Drugs Sales in Value by Country (2024-2029)
6 Europe Aneurysmal Subarachnoid Hemorrhage Drugs by Country
6.1 Europe Aneurysmal Subarachnoid Hemorrhage Drugs Historic Market Size by Country
6.1.1 Europe Aneurysmal Subarachnoid Hemorrhage Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Aneurysmal Subarachnoid Hemorrhage Drugs Sales in Volume by Country (2018-2023)
6.1.3 Europe Aneurysmal Subarachnoid Hemorrhage Drugs Sales in Value by Country (2018-2023)
6.2 Europe Aneurysmal Subarachnoid Hemorrhage Drugs Forecasted Market Size by Country
6.2.1 Europe Aneurysmal Subarachnoid Hemorrhage Drugs Sales in Volume by Country (2024-2029)
6.2.2 Europe Aneurysmal Subarachnoid Hemorrhage Drugs Sales in Value by Country (2024-2029)
7 Asia-Pacific Aneurysmal Subarachnoid Hemorrhage Drugs by Region
7.1 Asia-Pacific Aneurysmal Subarachnoid Hemorrhage Drugs Historic Market Size by Region
7.1.1 Asia-Pacific Aneurysmal Subarachnoid Hemorrhage Drugs Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Aneurysmal Subarachnoid Hemorrhage Drugs Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Aneurysmal Subarachnoid Hemorrhage Drugs Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Aneurysmal Subarachnoid Hemorrhage Drugs Forecasted Market Size by Region
7.2.1 Asia-Pacific Aneurysmal Subarachnoid Hemorrhage Drugs Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Aneurysmal Subarachnoid Hemorrhage Drugs Sales in Value by Region (2024-2029)
8 Latin America Aneurysmal Subarachnoid Hemorrhage Drugs by Country
8.1 Latin America Aneurysmal Subarachnoid Hemorrhage Drugs Historic Market Size by Country
8.1.1 Latin America Aneurysmal Subarachnoid Hemorrhage Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Aneurysmal Subarachnoid Hemorrhage Drugs Sales in Volume by Country (2018-2023)
8.1.3 Latin America Aneurysmal Subarachnoid Hemorrhage Drugs Sales in Value by Country (2018-2023)
8.2 Latin America Aneurysmal Subarachnoid Hemorrhage Drugs Forecasted Market Size by Country
8.2.1 Latin America Aneurysmal Subarachnoid Hemorrhage Drugs Sales in Volume by Country (2024-2029)
8.2.2 Latin America Aneurysmal Subarachnoid Hemorrhage Drugs Sales in Value by Country (2024-2029)
9 Middle East and Africa Aneurysmal Subarachnoid Hemorrhage Drugs by Country
9.1 Middle East and Africa Aneurysmal Subarachnoid Hemorrhage Drugs Historic Market Size by Country
9.1.1 Middle East and Africa Aneurysmal Subarachnoid Hemorrhage Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Aneurysmal Subarachnoid Hemorrhage Drugs Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Aneurysmal Subarachnoid Hemorrhage Drugs Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Aneurysmal Subarachnoid Hemorrhage Drugs Forecasted Market Size by Country
9.2.1 Middle East and Africa Aneurysmal Subarachnoid Hemorrhage Drugs Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Aneurysmal Subarachnoid Hemorrhage Drugs Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Arbor Pharmaceuticals
10.1.1 Arbor Pharmaceuticals Company Information
10.1.2 Arbor Pharmaceuticals Introduction and Business Overview
10.1.3 Arbor Pharmaceuticals Aneurysmal Subarachnoid Hemorrhage Drugs Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Arbor Pharmaceuticals Aneurysmal Subarachnoid Hemorrhage Drugs Products Offered
10.1.5 Arbor Pharmaceuticals Recent Development
10.2 PDS Biotechnology Corporation
10.2.1 PDS Biotechnology Corporation Company Information
10.2.2 PDS Biotechnology Corporation Introduction and Business Overview
10.2.3 PDS Biotechnology Corporation Aneurysmal Subarachnoid Hemorrhage Drugs Sales, Revenue and Gross Margin (2018-2023)
10.2.4 PDS Biotechnology Corporation Aneurysmal Subarachnoid Hemorrhage Drugs Products Offered
10.2.5 PDS Biotechnology Corporation Recent Development
10.3 Johnson and Johnson
10.3.1 Johnson and Johnson Company Information
10.3.2 Johnson and Johnson Introduction and Business Overview
10.3.3 Johnson and Johnson Aneurysmal Subarachnoid Hemorrhage Drugs Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Johnson and Johnson Aneurysmal Subarachnoid Hemorrhage Drugs Products Offered
10.3.5 Johnson and Johnson Recent Development
10.4 Mylan N.V
10.4.1 Mylan N.V Company Information
10.4.2 Mylan N.V Introduction and Business Overview
10.4.3 Mylan N.V Aneurysmal Subarachnoid Hemorrhage Drugs Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Mylan N.V Aneurysmal Subarachnoid Hemorrhage Drugs Products Offered
10.4.5 Mylan N.V Recent Development
10.5 Orexo AB
10.5.1 Orexo AB Company Information
10.5.2 Orexo AB Introduction and Business Overview
10.5.3 Orexo AB Aneurysmal Subarachnoid Hemorrhage Drugs Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Orexo AB Aneurysmal Subarachnoid Hemorrhage Drugs Products Offered
10.5.5 Orexo AB Recent Development
10.6 Pfizer
10.6.1 Pfizer Company Information
10.6.2 Pfizer Introduction and Business Overview
10.6.3 Pfizer Aneurysmal Subarachnoid Hemorrhage Drugs Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Pfizer Aneurysmal Subarachnoid Hemorrhage Drugs Products Offered
10.6.5 Pfizer Recent Development
10.7 Purdue Pharma
10.7.1 Purdue Pharma Company Information
10.7.2 Purdue Pharma Introduction and Business Overview
10.7.3 Purdue Pharma Aneurysmal Subarachnoid Hemorrhage Drugs Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Purdue Pharma Aneurysmal Subarachnoid Hemorrhage Drugs Products Offered
10.7.5 Purdue Pharma Recent Development
10.8 Pharmaxis
10.8.1 Pharmaxis Company Information
10.8.2 Pharmaxis Introduction and Business Overview
10.8.3 Pharmaxis Aneurysmal Subarachnoid Hemorrhage Drugs Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Pharmaxis Aneurysmal Subarachnoid Hemorrhage Drugs Products Offered
10.8.5 Pharmaxis Recent Development
10.9 Sun Pharmaceutical Industries
10.9.1 Sun Pharmaceutical Industries Company Information
10.9.2 Sun Pharmaceutical Industries Introduction and Business Overview
10.9.3 Sun Pharmaceutical Industries Aneurysmal Subarachnoid Hemorrhage Drugs Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Sun Pharmaceutical Industries Aneurysmal Subarachnoid Hemorrhage Drugs Products Offered
10.9.5 Sun Pharmaceutical Industries Recent Development
10.10 Teva Pharmaceutical
10.10.1 Teva Pharmaceutical Company Information
10.10.2 Teva Pharmaceutical Introduction and Business Overview
10.10.3 Teva Pharmaceutical Aneurysmal Subarachnoid Hemorrhage Drugs Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Teva Pharmaceutical Aneurysmal Subarachnoid Hemorrhage Drugs Products Offered
10.10.5 Teva Pharmaceutical Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Aneurysmal Subarachnoid Hemorrhage Drugs Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Aneurysmal Subarachnoid Hemorrhage Drugs Industrial Chain Analysis
11.4 Aneurysmal Subarachnoid Hemorrhage Drugs Market Dynamics
11.4.1 Aneurysmal Subarachnoid Hemorrhage Drugs Industry Trends
11.4.2 Aneurysmal Subarachnoid Hemorrhage Drugs Market Drivers
11.4.3 Aneurysmal Subarachnoid Hemorrhage Drugs Market Challenges
11.4.4 Aneurysmal Subarachnoid Hemorrhage Drugs Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Aneurysmal Subarachnoid Hemorrhage Drugs Distributors
12.3 Aneurysmal Subarachnoid Hemorrhage Drugs Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
List of Tables
Table 1. Major Company of Opioid Analgesic
Table 2. Major Company of Calcium Channel Blocker
Table 3. Major Company of Anticonvulsant
Table 4. Major Company of Stool Softener
Table 5. Major Company of Osmotic Agent
Table 6. Major Company of Other Drugs
Table 7. Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Type 2018 VS 2022 VS 2029 (US$ Million)
Table 8. Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Type (2018-2023) & (K MT)
Table 9. Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales Market Share in Volume by Type (2018-2023)
Table 10. Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Type (2018-2023) & (US& Million)
Table 11. Global Aneurysmal Subarachnoid Hemorrhage Drugs Market Share in Value by Type (2018-2023)
Table 12. Global Aneurysmal Subarachnoid Hemorrhage Drugs Price by Type (2018-2023) & (USD/MT)
Table 13. Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Type (2024-2029) & (K MT)
Table 14. Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales Market Share in Volume by Type (2024-2029)
Table 15. Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Type (2024-2029) & (US$ Million)
Table 16. Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales Market Share in Value by Type (2024-2029)
Table 17. Global Aneurysmal Subarachnoid Hemorrhage Drugs Price by Type (2024-2029) & (USD/MT)
Table 18. North America Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Type (2018-2023) & (K MT)
Table 19. North America Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Type (2018-2023) & (US$ Million)
Table 20. Europe Aneurysmal Subarachnoid Hemorrhage Drugs Sales (K MT) by Type (2018-2023)
Table 21. Europe Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Type (2018-2023) & (US$ Million)
Table 22. Asia-Pacific Aneurysmal Subarachnoid Hemorrhage Drugs Sales (K MT) by Type (2018-2023)
Table 23. Asia-Pacific Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Type (2018-2023) & (US$ Million)
Table 24. Latin America Aneurysmal Subarachnoid Hemorrhage Drugs Sales (K MT) by Type (2018-2023)
Table 25. Latin America Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Type (2018-2023) & (US$ Million)
Table 26. Middle East and Africa Aneurysmal Subarachnoid Hemorrhage Drugs Sales (K MT) by Type (2018-2023)
Table 27. Middle East and Africa Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Type (2018-2023) & (US$ Million)
Table 28. Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Company (2018-2023) & (K MT)
Table 29. Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales Share by Company (2018-2023)
Table 30. Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue by Company (2018-2023) & (US$ Million)
Table 31. Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Share by Company (2018-2023)
Table 32. Global Market Aneurysmal Subarachnoid Hemorrhage Drugs Price by Company (2018-2023) & (USD/MT)
Table 33. Global Aneurysmal Subarachnoid Hemorrhage Drugs Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 34. Global Aneurysmal Subarachnoid Hemorrhage Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 35. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Aneurysmal Subarachnoid Hemorrhage Drugs as of 2022)
Table 36. Date of Key Manufacturers Enter into Aneurysmal Subarachnoid Hemorrhage Drugs Market
Table 37. Key Manufacturers Aneurysmal Subarachnoid Hemorrhage Drugs Product Type
Table 38. Mergers & Acquisitions, Expansion Plans
Table 39. Global Aneurysmal Subarachnoid Hemorrhage Drugs Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
Table 40. Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Region (2018-2023) & (K MT)
Table 41. Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales Market Share in Volume by Region (2018-2023)
Table 42. Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Region (2018-2023) & (US$ Million)
Table 43. Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales Market Share in Value by Region (2018-2023)
Table 44. Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 45. Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Region (2024-2029) & (K MT)
Table 46. Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales Market Share in Volume by Region (2024-2029)
Table 47. Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Region (2024-2029) & (US$ Million)
Table 48. Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales Market Share in Value by Region (2024-2029)
Table 49. Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2024-2029)
Table 50. Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)
Table 51. Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Application (2018-2023) & (K MT)
Table 52. Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales Market Share in Volume by Application (2018-2023)
Table 53. Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Application (2018-2023) & (US$ Million)
Table 54. Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales Market Share in Value by Application (2018-2023)
Table 55. Global Aneurysmal Subarachnoid Hemorrhage Drugs Price by Application (2018-2023) & (USD/MT)
Table 56. Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Application (2024-2029) & (K MT)
Table 57. Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales Market Share in Volume by Application (2024-2029)
Table 58. Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Application (2024-2029) & (US$ Million)
Table 59. Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales Market Share in Value by Application (2024-2029)
Table 60. Global Aneurysmal Subarachnoid Hemorrhage Drugs Price by Application (2024-2029) & (USD/MT)
Table 61. North America Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Application (2018-2023) (K MT)
Table 62. North America Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Application (2018-2023) & (US$ Million)
Table 63. Europe Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Application (2018-2023) (K MT)
Table 64. Europe Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Application (2018-2023) & (US$ Million)
Table 65. Asia-Pacific Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Application (2018-2023) (K MT)
Table 66. Asia-Pacific Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Application (2018-2023) & (US$ Million)
Table 67. Latin America Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Application (2018-2023) (K MT)
Table 68. Latin America Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Application (2018-2023) & (US$ Million)
Table 69. Middle East and Africa Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Application (2018-2023) (K MT)
Table 70. Middle East and Africa Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Application (2018-2023) & (US$ Million)
Table 71. North America Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Country (2018-2023) & (K MT)
Table 72. North America Aneurysmal Subarachnoid Hemorrhage Drugs Sales Market Share in Volume by Country (2018-2023)
Table 73. North America Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Country (2018-2023) & (US$ Million)
Table 74. North America Aneurysmal Subarachnoid Hemorrhage Drugs Sales Market Share in Value by Country (2018-2023)
Table 75. North America Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Country (2024-2029) & (K MT)
Table 76. North America Aneurysmal Subarachnoid Hemorrhage Drugs Sales Market Share in Volume by Country (2024-2029)
Table 77. North America Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Country (2024-2029) & (US$ Million)
Table 78. North America Aneurysmal Subarachnoid Hemorrhage Drugs Sales Market Share in Value by Country (2024-2029)
Table 79. Europe Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Country (2018-2023) & (K MT)
Table 80. Europe Aneurysmal Subarachnoid Hemorrhage Drugs Sales Market Share in Volume by Country (2018-2023)
Table 81. Europe Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Country (2018-2023) & (US$ Million)
Table 82. Europe Aneurysmal Subarachnoid Hemorrhage Drugs Sales Market Share in Value by Country (2018-2023)
Table 83. Europe Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Country (2024-2029) & (K MT)
Table 84. Europe Aneurysmal Subarachnoid Hemorrhage Drugs Sales Market Share in Volume by Country (2024-2029)
Table 85. Europe Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Country (2024-2029) & (US$ Million)
Table 86. Europe Aneurysmal Subarachnoid Hemorrhage Drugs Sales Market Share in Value by Country (2024-2029)
Table 87. Asia-Pacific Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Region (2018-2023) & (K MT)
Table 88. Asia-Pacific Aneurysmal Subarachnoid Hemorrhage Drugs Sales Market Share in Volume by Region (2018-2023)
Table 89. Asia-Pacific Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Region (2018-2023) & (US$ Million)
Table 90. Asia-Pacific Aneurysmal Subarachnoid Hemorrhage Drugs Sales Market Share in Value by Region (2018-2023)
Table 91. Asia-Pacific Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Region (2024-2029) & (K MT)
Table 92. Asia-Pacific Aneurysmal Subarachnoid Hemorrhage Drugs Sales Market Share in Volume by Region (2024-2029)
Table 93. Asia-Pacific Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Region (2024-2029) & (US$ Million)
Table 94. Asia-Pacific Aneurysmal Subarachnoid Hemorrhage Drugs Sales Market Share in Value by Region (2024-2029)
Table 95. Latin America Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Country (2018-2023) & (K MT)
Table 96. Latin America Aneurysmal Subarachnoid Hemorrhage Drugs Sales Market Share in Volume by Country (2018-2023)
Table 97. Latin America Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Country (2018-2023) & (US$ Million)
Table 98. Latin America Aneurysmal Subarachnoid Hemorrhage Drugs Sales Market Share in Value by Country (2018-2023)
Table 99. Latin America Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Country (2024-2029) & (K MT)
Table 100. Latin America Aneurysmal Subarachnoid Hemorrhage Drugs Sales Market Share in Volume by Country (2024-2029)
Table 101. Latin America Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Country (2024-2029) & (US$ Million)
Table 102. Latin America Aneurysmal Subarachnoid Hemorrhage Drugs Sales Market Share in Value by Country (2024-2029)
Table 103. Middle East and Africa Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Country (2018-2023) & (K MT)
Table 104. Middle East and Africa Aneurysmal Subarachnoid Hemorrhage Drugs Sales Market Share in Volume by Country (2018-2023)
Table 105. Middle East and Africa Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Country (2018-2023) & (US$ Million)
Table 106. Middle East and Africa Aneurysmal Subarachnoid Hemorrhage Drugs Sales Market Share in Value by Country (2018-2023)
Table 107. Middle East and Africa Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Country (2024-2029) & (K MT)
Table 108. Middle East and Africa Aneurysmal Subarachnoid Hemorrhage Drugs Sales Market Share in Volume by Country (2024-2029)
Table 109. Middle East and Africa Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Country (2024-2029) & (US$ Million)
Table 110. Middle East and Africa Aneurysmal Subarachnoid Hemorrhage Drugs Sales Market Share in Value by Country (2024-2029)
Table 111. Arbor Pharmaceuticals Company Information
Table 112. Arbor Pharmaceuticals Introduction and Business Overview
Table 113. Arbor Pharmaceuticals Aneurysmal Subarachnoid Hemorrhage Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 114. Arbor Pharmaceuticals Aneurysmal Subarachnoid Hemorrhage Drugs Product
Table 115. Arbor Pharmaceuticals Recent Development
Table 116. PDS Biotechnology Corporation Company Information
Table 117. PDS Biotechnology Corporation Introduction and Business Overview
Table 118. PDS Biotechnology Corporation Aneurysmal Subarachnoid Hemorrhage Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 119. PDS Biotechnology Corporation Aneurysmal Subarachnoid Hemorrhage Drugs Product
Table 120. PDS Biotechnology Corporation Recent Development
Table 121. Johnson and Johnson Company Information
Table 122. Johnson and Johnson Introduction and Business Overview
Table 123. Johnson and Johnson Aneurysmal Subarachnoid Hemorrhage Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 124. Johnson and Johnson Aneurysmal Subarachnoid Hemorrhage Drugs Product
Table 125. Johnson and Johnson Recent Development
Table 126. Mylan N.V Company Information
Table 127. Mylan N.V Introduction and Business Overview
Table 128. Mylan N.V Aneurysmal Subarachnoid Hemorrhage Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 129. Mylan N.V Aneurysmal Subarachnoid Hemorrhage Drugs Product
Table 130. Mylan N.V Recent Development
Table 131. Orexo AB Company Information
Table 132. Orexo AB Introduction and Business Overview
Table 133. Orexo AB Aneurysmal Subarachnoid Hemorrhage Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 134. Orexo AB Aneurysmal Subarachnoid Hemorrhage Drugs Product
Table 135. Orexo AB Recent Development
Table 136. Pfizer Company Information
Table 137. Pfizer Introduction and Business Overview
Table 138. Pfizer Aneurysmal Subarachnoid Hemorrhage Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 139. Pfizer Aneurysmal Subarachnoid Hemorrhage Drugs Product
Table 140. Pfizer Recent Development
Table 141. Purdue Pharma Company Information
Table 142. Purdue Pharma Introduction and Business Overview
Table 143. Purdue Pharma Aneurysmal Subarachnoid Hemorrhage Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 144. Purdue Pharma Aneurysmal Subarachnoid Hemorrhage Drugs Product
Table 145. Purdue Pharma Recent Development
Table 146. Pharmaxis Company Information
Table 147. Pharmaxis Introduction and Business Overview
Table 148. Pharmaxis Aneurysmal Subarachnoid Hemorrhage Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 149. Pharmaxis Aneurysmal Subarachnoid Hemorrhage Drugs Product
Table 150. Pharmaxis Recent Development
Table 151. Sun Pharmaceutical Industries Company Information
Table 152. Sun Pharmaceutical Industries Introduction and Business Overview
Table 153. Sun Pharmaceutical Industries Aneurysmal Subarachnoid Hemorrhage Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 154. Sun Pharmaceutical Industries Aneurysmal Subarachnoid Hemorrhage Drugs Product
Table 155. Sun Pharmaceutical Industries Recent Development
Table 156. Teva Pharmaceutical Company Information
Table 157. Teva Pharmaceutical Introduction and Business Overview
Table 158. Teva Pharmaceutical Aneurysmal Subarachnoid Hemorrhage Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 159. Teva Pharmaceutical Aneurysmal Subarachnoid Hemorrhage Drugs Product
Table 160. Teva Pharmaceutical Recent Development
Table 161. Key Raw Materials Lists
Table 162. Raw Materials Key Suppliers Lists
Table 163. Aneurysmal Subarachnoid Hemorrhage Drugs Market Trends
Table 164. Aneurysmal Subarachnoid Hemorrhage Drugs Market Drivers
Table 165. Aneurysmal Subarachnoid Hemorrhage Drugs Market Challenges
Table 166. Aneurysmal Subarachnoid Hemorrhage Drugs Market Restraints
Table 167. Aneurysmal Subarachnoid Hemorrhage Drugs Distributors List
Table 168. Aneurysmal Subarachnoid Hemorrhage Drugs Downstream Customers
Table 169. Research Programs/Design for This Report
Table 170. Key Data Information from Secondary Sources
Table 171. Key Data Information from Primary Sources
List of Figures
Figure 1. Aneurysmal Subarachnoid Hemorrhage Drugs Product Picture
Figure 2. Global Aneurysmal Subarachnoid Hemorrhage Drugs Market Size, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Aneurysmal Subarachnoid Hemorrhage Drugs Market Size Status and Outlook (2018-2029) & (US$ Million)
Figure 4. Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales Status and Outlook (2018-2029) & (K MT)
Figure 5. Product Picture of Opioid Analgesic
Figure 6. Global Opioid Analgesic Sales YoY Growth (2018-2029) & (K MT)
Figure 7. Product Picture of Calcium Channel Blocker
Figure 8. Global Calcium Channel Blocker Sales YoY Growth (2018-2029) & (K MT)
Figure 9. Product Picture of Anticonvulsant
Figure 10. Global Anticonvulsant Sales YoY Growth (2018-2029) & (K MT)
Figure 11. Product Picture of Stool Softener
Figure 12. Global Stool Softener Sales YoY Growth (2018-2029) & (K MT)
Figure 13. Product Picture of Osmotic Agent
Figure 14. Global Osmotic Agent Sales YoY Growth (2018-2029) & (K MT)
Figure 15. Product Picture of Other Drugs
Figure 16. Global Other Drugs Sales YoY Growth (2018-2029) & (K MT)
Figure 17. Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Type (2018-2029) & (US$ Million)
Figure 18. Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales Market Share by Type in 2022 & 2029
Figure 19. North America Aneurysmal Subarachnoid Hemorrhage Drugs Sales Market Share in Volume by Type in 2022

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs